High-speed atomic force microscopy highlights new molecular mechanism of daptomycin action
- PMID: 33298927
- PMCID: PMC7725780
- DOI: 10.1038/s41467-020-19710-z
High-speed atomic force microscopy highlights new molecular mechanism of daptomycin action
Abstract
The increase in speed of the high-speed atomic force microscopy (HS-AFM) compared to that of the conventional AFM made possible the first-ever visualisation at the molecular-level of the activity of an antimicrobial peptide on a membrane. We investigated the medically prescribed but poorly understood lipopeptide Daptomycin under infection-like conditions (37 °C, bacterial lipid composition and antibiotic concentrations). We confirmed so far hypothetical models: Dap oligomerization and the existence of half pores. Moreover, we detected unknown molecular mechanisms: new mechanisms to form toroidal pores or to resist Dap action, and to unprecedently quantify the energy profile of interacting oligomers. Finally, the biological and medical relevance of the findings was ensured by a multi-scale multi-nativeness-from the molecule to the cell-correlation of molecular-level information from living bacteria (Bacillus subtilis strains) to liquid-suspended vesicles and supported-membranes using electron and optical microscopies and the lipid tension probe FliptR, where we found that the cells with a healthier state of their cell wall show smaller membrane deformations.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Reddy K, Yedery R, Aranha C. Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents. 2004;24:536–547. - PubMed
-
- Boman H. Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med. 2003;254:197–215. - PubMed
-
- Pirri G, Giuliani A, Nicoletto SF, Pizzuto L, Rinaldi AC. Lipopeptides as anti-infectives: a practical perspective. Cent. Eur. J. Biol. 2009;4:258–273.
-
- Hashizume, H. & Nishimura, Y. Studies in Natural Products Chemistry. Vol. 35, 693–751 (Elsevier, 2008).
-
- Yin N, et al. Structure–activity relationship studies of a series of semisynthetic lipopeptides leading to the discovery of Surotomycin, a novel cyclic lipopeptide being developed for the treatment of Clostridium difficile-associated diarrhea. J. Med. Chem. 2015;58:5137–5142. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
